Accueil   Diary - News   All news Noah D. Beerman Joins POXEL as Executive Vice President, Business Development and President, US Operations

Noah D. Beerman Joins POXEL as Executive Vice President, Business Development and President, US Operations

POXEL, a biopharmaceutical company developing innovative drugs to treat type 2 diabetes, announced that Noah D. Beerman has joined the company as Executive Vice President, Business Development and President, US Operations to spearhead Poxel’s expanding presence into the USA. Mr. Beerman will be based in the Boston area, and is responsible for leading Poxel’s global business development efforts, and for continuing to build the Company’s relationships with the US financial community.

 

Read the press release 

 

POXEL HOME

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree